Tick off the contraceptive options now available at your clinic. If you are a provider at a university health center, chances are your list may be shorter than it was in 2007.
With results just published for a Phase I clinical trial and data for a Phase I/II trial in analysis, developers of what is being dubbed the Invisible Condom are looking toward initiation of a Phase III randomized controlled trial to test the safety and efficacy of the potential microbicide.
Results from a new Guttmacher Institute analysis indicate that current state-mandated abortion counseling requirements often violate core principles of informed consent.
What percentage of women choose sterilization as their contraceptive option in your practice? Chances are it is a significant proportion. According to the National Center for Health Statistics, 17% of all women ages 15-44 rely on female sterilization for birth control.
The number, type, and severity of comorbidities are important determinants of diabetes self-care.
Patients with mild-to-moderate obstructive sleep apnea (OSA) who were treated with Continuous Positive Airway Pressure (CPAP) experienced an absolute risk reduction in cardiovascular risk compared with those who were not treated.
Absent or low testosterone levels in men appear to have a pathogenic role in the development of cardiovascular disease resulting in increased cardiovascular and all-cause mortality and are not simply "markers" for illness or wellness.
The FDA has approved, by priority review, the first drug to help manage patients with phenylketonuria (PKU).
Fenofibrate for Diabetic Retinopathy, Does Obesity Cause A Delay in Diagnosis of Prostate Cancer?, and Protecting Bone During Glucocorticoid Treatment
